- Cell Biology
- Product Type
- Research Area
- New Products
- About Tocris
- Contact Us
16th March 2021
Bio-Techne subsidiary Tocris Bioscience, based in Bristol, UK, receives ISO 9001:2015 Quality Management Systems Certification.
6th November 2019
Bio-Techne has acquired a license from C4 Therapeutics to the new aTAG platform for selective degradation of specific proteins within cells.
8th August 2018
Tocris has launched the first GMP small molecules for use as ancillary reagents (raw materials) in the further manufacture of stem cell therapies.
13th December 2016
Tocris Bioscience has signed an agreement with Brigham and Women's Hospital, Boston (USA), to acquire an exclusive license for LDN 193189.
7th December 2016
Tocris Bioscience has announced a collaboration with the Chemical Probes Portal to help scientists find and purchase the best small molecule reagents for their research.
7th November 2016
Tocris Bioscience, part of the Biotechnology division of Bio-Techne, today announced the launch of its new compound library, Tocriscreen™ Plus.